Linda E. Chovan

747 total citations
13 papers, 354 citations indexed

About

Linda E. Chovan is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Linda E. Chovan has authored 13 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Linda E. Chovan's work include Herpesvirus Infections and Treatments (3 papers), Toxoplasma gondii Research Studies (3 papers) and Pesticide Residue Analysis and Safety (2 papers). Linda E. Chovan is often cited by papers focused on Herpesvirus Infections and Treatments (3 papers), Toxoplasma gondii Research Studies (3 papers) and Pesticide Residue Analysis and Safety (2 papers). Linda E. Chovan collaborates with scholars based in United States, United Kingdom and France. Linda E. Chovan's co-authors include Dominique Aubert, Jeff Hunt, Isabelle Villena, G T Maine, Peter J. Dandliker, J. M. Pinon, Yau Yi Lau, Paul Hessler, Karl Reich and John S. Tyner and has published in prestigious journals such as Journal of Molecular Biology, Journal of Bacteriology and Journal of Clinical Microbiology.

In The Last Decade

Linda E. Chovan

13 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linda E. Chovan United States	9	183	178	109	47	44	13	354
Anke Harupa United States	11	116 0.6×	134 0.8×	196 1.8×	38 0.8×	25 0.6×	12	666
R. Richle Switzerland	10	158 0.9×	108 0.6×	152 1.4×	34 0.7×	23 0.5×	14	650
Valentine Duru Cambodia	5	127 0.7×	138 0.8×	109 1.0×	30 0.6×	123 2.8×	7	865
Christopher L. Peatey Australia	13	69 0.4×	54 0.3×	83 0.8×	31 0.7×	56 1.3×	16	517
B. Merkli Switzerland	6	84 0.5×	101 0.6×	146 1.3×	38 0.8×	14 0.3×	8	603
Katja Fischer Germany	8	51 0.3×	58 0.3×	94 0.9×	27 0.6×	52 1.2×	12	459
Heather Houston United States	6	201 1.1×	78 0.4×	56 0.5×	35 0.7×	39 0.9×	6	309
Jan Haviernik Czechia	11	51 0.3×	68 0.4×	66 0.6×	21 0.4×	193 4.4×	18	360
Gregory Tullo United States	8	51 0.3×	82 0.5×	107 1.0×	32 0.7×	57 1.3×	13	650
Ewelina Król Poland	10	133 0.7×	19 0.1×	172 1.6×	10 0.2×	147 3.3×	33	432

Countries citing papers authored by Linda E. Chovan

Since Specialization

Citations

This map shows the geographic impact of Linda E. Chovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda E. Chovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda E. Chovan more than expected).

Fields of papers citing papers by Linda E. Chovan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda E. Chovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda E. Chovan. The network helps show where Linda E. Chovan may publish in the future.

Co-authorship network of co-authors of Linda E. Chovan

This figure shows the co-authorship network connecting the top 25 collaborators of Linda E. Chovan. A scholar is included among the top collaborators of Linda E. Chovan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda E. Chovan. Linda E. Chovan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kempf, Dale J., Cheri E. Klein, Hui-Ju Chen, et al.. (2007). Pharmacokinetic Enhancement of the Hepatitis C Virus Protease Inhibitors VX-950 and SCH 503034 by Co-Dosing with Ritonavir. Antiviral chemistry & chemotherapy. 18(3). 163–167. 33 indexed citations

Wang, Xueqing, Teodozyi Kolasa, Linda E. Chovan, et al.. (2007). Rapid hit to lead evaluation of pyrazolo[3,4-d]pyrimidin-4-one as selective and orally bioavailable mGluR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(15). 4303–4307. 16 indexed citations

Chovan, Linda E., et al.. (2006). Solid Phase Extraction as a Faster Alternative to HPLC: Application to MS Analysis of Metabolic Stability Samples. Journal of Pharmaceutical Sciences. 96(6). 1619–1624. 5 indexed citations

Kempf, Dale J., Clinton M. Yeung, John T. Randolph, et al.. (2006). 4 Pharmacokinetic boosting of VX-950, an inhibitor of HCV protease, by co-dosing with ritonavir. Journal of Hepatology. 44. S4–S4. 4 indexed citations

Hinman, Mira M., Linda E. Chovan, Douglas Kalvin, et al.. (2006). Novel Antibacterial Class: A Series of Tetracyclic Derivatives. Journal of Medicinal Chemistry. 49(16). 4842–4856. 7 indexed citations

Hansen, Terkel, Peter J. Dandliker, Linda E. Chovan, et al.. (2005). Synthesis and antibacterial activity of 5-methoxy- and 5-hydroxy-6-fluoro-1,8-naphthyridone-3-carboxylic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 15(11). 2716–2719. 4 indexed citations

Pratt, Steven, Peter J. Dandliker, Xiaoling Xuei, et al.. (2004). A Strategy for Discovery of Novel Broad-Spectrum Antibacterials Using a High-Throughput Streptococcus pneumoniae Transcription/Translation Screen. SLAS DISCOVERY. 9(1). 3–11. 22 indexed citations

Chovan, Linda E., et al.. (2004). Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays. Rapid Communications in Mass Spectrometry. 18(24). 3105–3112. 30 indexed citations

Yu, Liping, Angelo Gunasekera, J. Mack, et al.. (2001). Solution structure and function of a conserved protein SP14.3 encoded by an essential Streptococcus pneumoniae gene 1 1Edited by M. F. Summers. Journal of Molecular Biology. 311(3). 593–604. 18 indexed citations

10.

Aubert, Dominique, G T Maine, Isabelle Villena, et al.. (2000). Recombinant Antigens To DetectToxoplasma gondii-Specific Immunoglobulin G and Immunoglobulin M in Human Sera by Enzyme Immunoassay. Journal of Clinical Microbiology. 38(3). 1144–1150. 141 indexed citations

11.

Reich, Karl, Linda E. Chovan, & Paul Hessler. (1999). Genome Scanning in Haemophilus influenzae for Identification of Essential Genes. Journal of Bacteriology. 181(16). 4961–4968. 28 indexed citations

12.

Bonhomme, Annie, Gregory T. Maine, A. Beorchia, et al.. (1998). Quantitative Immunolocalization of a P29 Protein (GRA7), a New Antigen of Toxoplasma Gondii. Journal of Histochemistry & Cytochemistry. 46(12). 1411–1421. 36 indexed citations

13.

Maine, G T, et al.. (1996). The DNA-binding protein pUL57 of human cytomegalovirus: comparison of specific immunoglobulin M (IgM) reactivity with IgM reactivity to other major target antigens. Clinical and Diagnostic Laboratory Immunology. 3(3). 358–360. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact